Autologous platelet concentrate in the treatment of macular holes;Autologe thrombozytenapplikation bei der behandlung des idiopathischen makulaforamens

Ophthalmologe

Volumn 94, Issue 12, 1997, Pages 877-881

  Faude, F ^a   Edel, E ^b   Dannhauer, M ^b   Petzel, C ^a   Meier, P ^a   Wiedemann, P ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Autologous platelet concentrate; Growth factors; Macular holes; Muller cells; Vitrectomy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; THROMBOCYTE CONCENTRATE;

AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MUELLER CELL; RETINA MACULA HOLE; VISUAL ACUITY; VITRECTOMY;

EID: 0031416513     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050215     Document Type: Article

References (21)

1. Christmas NJ, Skolik SA, Howard MA, Saito Y, Barnstable CJ, Ligett PE (1995) Treatment of retinal breaks with autologous serum in an experimental model. Ophthalmology 102: 263-271
2. Freeman WR, Azen SP, Kim JW, El-Haig W, Mishell DR, Bailey I (1997) Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Arch Ophthalmol 115: 11-21
3. Funata M, Wendel RT, Cruz Z de la, Green WR (1992) Clinopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 12: 289-298
4. Gass DM (1988) Idiopathic senile macular hole. Early stages and pathogenesis. Arch Ophthalmol 106: 626-639
5. Gass JDM (1995) Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119: 752-759
6. Gaudric A, Massin P, Paques M (1995) Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 233: 549-554
7. 2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology 99: 1162-1173
8. Heidenkummer HP, Kampik A (1996) Morphologische Analyse epiretinaler Membranen bei chirurgisch behandelten idiopathischen Makulaforamina. Ophthalmologe 93: 675-679
9. Hitaizumi Y, Transfeldt EE, Kawahara N, Sung JH, Knighton D, Fiegel VD (1993) In vitro angiogenesis by platelet-derived wound-healing formula in injured spinal cord. Brain Res Bull 30: 353-357
10. Ibelgaufts H (ed) (1995) Dictionary of cytokines. VCH, Weinheim, pp 754-756
11. Ideka T, Puro DG (1995) Regulation of retinal glial cell proliferation by antiproliferation molecules. Exp Eye Res 60: 435-444
12. Knapp H (1869) Über isolierte Zerreißung der Aderhaut infolge von Traumen auf dem Augapfel. Arch Augenheilkd 1: 6
13. Kelly NE, Wendel RT (1991) Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 109: 654-659
14. Lewis GP, Erickson PA, Guerin CJ, Anderson DH, Fisher SK (1992) Basic fibroblast growth factor: a potential regulator of proliferation and intermediate filament expression in the retina. J Neuroscience 12: 3968-3978
15. Ligett PE, Skolik SA, Horio B, Saito Y, Alfaro V, Mieler W (1995) Human autologous serum for the treatment of full-thickness macular holes. Ophthalmology 102: 1071-1076
16. Madreperla SA, Geiger GL, Funata M (1994) Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 97: 843
17. Moroff G, Holme S (1991) Concept about current conditions for the preparation and storage of platelets. Transfus Med Rev 5: 48-59
18. Sagar SM, Edwards RM, Sharp FR (1991) Epidermal growth factor and transforming growth factor an induce c-fos gene expression in retinal Müller cells in vivo. J Neurosci Res 29: 549-559
19. Smiddy WE, Glaser BM, Green WR, Connor TB, Roberts AB, Lucas R, Sporn MB (1989) Transforming growth factor beta: a biologic chorioretinal glue. Arch Ophthalmol 107: 577-580
20. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW (1992) Randomized prospective double-blind trial in treating chronic diabetic foot ulcers CT102 activated platelet supernatant, topical versus placebo. Diabetes. Care 15: 1598-1604
21. Uchiori Y, Puro DG (1991) Mitogenic and chemotactic effects of platelet derived growth factor in human retinal glial cells. Invest Ophthalmol Vis Sci 32: 2689-2695